Global Hepatitis Diagnostics Test Market to reach USD 6.96 billion by 2026

Global Hepatitis Diagnostics Test Market Size Study, By Test (Blood Test, Imaging Test, and liver Biopsy) and Regional Forecasts 2019-2026
Product Code:  HALMD_95913956
Chapter 1.	Executive Summary  
1.1.	Market Snapshot
1.2.	Global & Segmental Market Estimates & Forecasts, 2017-2026 (USD Billion)
1.2.1.	Hepatitis Diagnostic Test Market, by Test Type, 2017-2026 (USD Billion)
1.2.2.	Hepatitis Diagnostic Test Market, by Region, 2017-2026 (USD Billion)
1.3.	Key Trends
1.4.	Estimation Methodology
1.5.	Research Assumption
Chapter 2.	Global Hepatitis Diagnostic Test Market Definition and Scope 
2.1.	Objective of the Study
2.2.	Market Definition & Scope
2.2.1.	Scope of the Study
2.2.2.	Industry Evolution
2.3.	Years Considered for the Study
2.4.	Currency Conversion Rates
Chapter 3.	Global Hepatitis Diagnostic Test Market Dynamics	
3.1.	Hepatitis Diagnostic Test Market Impact Analysis (2018-2026)
3.1.1.	Market Drivers
3.1.2.	Market Challenges
3.1.3.	Market Opportunities
Chapter 4.	Global Hepatitis Diagnostic Test Market Analysis
4.1.	Porter’s 5 Force Model
4.1.1.	Bargaining Power of Suppliers
4.1.2.	Bargaining Power of Buyers
4.1.3.	Threat of New Entrants
4.1.4.	Threat of Substitutes
4.1.5.	Competitive Rivalry
4.1.6.	Futuristic Approach to Porter’s 5 Force Model (2016-2026)
4.2.	PEST Analysis
4.2.1.	Political 
4.2.2.	Economical
4.2.3.	Social 
4.2.4.	Technological 
4.3.	Investment Adoption Model
4.4.	Analyst Recommendation & Conclusion
Chapter 5.	Global Hepatitis Diagnostic Test Market, by Test Type 
5.1.	Market Snapshot 
5.2.	Global Hepatitis Diagnostic Test Market by Test Type, Performance - Potential Analysis
5.3.	Global Hepatitis Diagnostic Test Market Estimates & Forecasts by Test Type, 2016-2026 (USD Billion)
5.4.	Hepatitis Diagnostic Test Market, Sub Segment Analysis
5.4.1.	Blood Test
5.4.2.	Imaging Test
5.4.3.	Liver Biopsy
Chapter 6.	Global Hepatitis Diagnostic Test Market, Regional Analysis
6.1.	Hepatitis Diagnostic Test Market, Regional Market Snapshot 
6.2.	North America Hepatitis Diagnostic Test Market 
6.2.1.	U.S. Hepatitis Diagnostic Test Market	Test Type breakdown estimates & forecasts, 2016-2026
6.2.2.	Canada Hepatitis Diagnostic Test Market
6.3.	Europe Hepatitis Diagnostic Test Market Snapshot
6.3.1.	U.K. Hepatitis Diagnostic Test Market
6.3.2.	Germany Hepatitis Diagnostic Test Market
6.3.3.	Rest of Europe Hepatitis Diagnostic Test Market
6.4.	Asia-Pacific Hepatitis Diagnostic Test Market Snapshot
6.4.1.	China Hepatitis Diagnostic Test Market 
6.4.2.	India Hepatitis Diagnostic Test Market 
6.4.3.	Japan Hepatitis Diagnostic Test Market
6.4.4.	Rest of Asia Pacific Hepatitis Diagnostic Test Market
6.5.	Latin America Hepatitis Diagnostic Test Market Snapshot
6.5.1.	Brazil Hepatitis Diagnostic Test Market
6.5.2.	Mexico Hepatitis Diagnostic Test Market
6.6.	Rest of The World Hepatitis Diagnostic Test Market
Chapter 7.	Competitive Intelligence
7.1.	Top Market Strategies
7.2.	Company Profiles
7.2.1.	Siemens AG	Overview	Financial (Subject to Data Availability)	Product Summary	Recent Developments
7.2.2.	Abbott Laboratories
7.2.3.	MedMira Inc
7.2.4.	Qaigen Inc
7.2.5.	Diasorin S.p.A
7.2.6.	Hologic Inc
7.2.7.	Bio-Rad Laboratories Inc
7.2.8.	bioMeriuex
7.2.9.	Beckman Coulter Inc (Danaher Corporation)
7.2.10.	F. Hoffmann Roche
Chapter 8.	 Research Process
8.1.	Research Process
8.1.1.	Data Mining
8.1.2.	Analysis
8.1.3.	Market Estimation
8.1.4.	Validation
8.1.5.	Publishing
8.2.	Research Attributes
8.3.	Research Assumption

Global Hepatitis Diagnostics Test industry valued approximately USD 4.11 billion in 2018 is anticipated to grow with a healthy growth rate of more than 6.81% over the forecast period 2019-2026. The term Hepatitis broadly means inflammation of the liver. Heavy alcohol use, some medications, toxins, and certain medical conditions can cause hepatitis. Also, hepatitis is often caused due to viral infection. Several factors such as increasing awareness for monitoring and screening procedures, increasing prevalence of hepatitis and growing demand for diagnostic techniques are likely to force the demand for hepatitis diagnostic test in the global market over the forecast period. For instance, as per the World Health Organization data of 2018, around 257 million people are living with hepatitis B virus infection. However, limited facilities or services for hepatitis testing along with limited access to reliable and low-cost HBV and HCV diagnostics are few factors restraining the growth of the market over the forecast period.
On the basis of test segment, liver biopsy is anticipated to represent most profitable share in the global hepatitis diagnostic tests market during the forecast period. The growth of liver biopsy segment is mainly attributed due to it provide high accurate results even in small samples compared to traditional tests. Also, the versatile applications and ease of diagnosis have made liver biopsy quite more popular in the recent years.
The regional analysis of Hepatitis Diagnostics Test market is considered for the key regions such as North America, Europe, Asia Pacific, Latin America and ROW. North America holds the leading position in critical care diagnostics market owing to the presence of well-developed healthcare infrastructure along with broad presence of prominent players in the region. Whereas, Asia-Pacific is expected to emerge as the fastest growing region in terms of market share. The growth of Asia-Pacific region is witnessed owing to rising prevalence of hepatitis especially in countries such as India and China, along with rising commercial availability of advanced products across the region.
The key manufacturers involved in the market are:
Siemens AG
Abbott Laboratories
MedMira Inc
Qaigen Inc
Diasorin S.p.A
Hologic Inc
Bio-Rad Laboratories Inc
Beckman Coulter Inc (Danaher Corporation)
F. Hoffmann Roche
The objective of the study is to define market sizes of different segments & countries in recent years and to forecast the values to the coming eight years. The report is designed to incorporate both qualitative and quantitative aspects of the industry within each of the regions and countries involved in the study. Furthermore, the report also caters the detailed information about the crucial aspects such as driving factors & challenges which will define the future growth of the market. Additionally, the report shall also incorporate available opportunities in micro markets for stakeholders to invest along with the detailed analysis of competitive landscape and product offerings of key players. The detailed segments and sub-segment of the market are explained below:
By Test Type:
Blood Test
Imaging Test
Liver Biopsy
North America
Asia Pacific
Latin America
Rest of the World
Furthermore, years considered for the study are as follows:
Historical year – 2016, 2017
Base year – 2018
Forecast period – 2019 to 2026
Target Audience of the Hepatitis Diagnostics Test Market Study:
Key Consulting Companies & Advisors
Large, medium-sized, and small enterprises
Venture capitalists
Value-Added Resellers (VARs)
Third-party knowledge providers
Investment bankers

We offer 10% free customization including country-level data, niche applications and competitive landscape with every report. This also includes a 30 minute free analyst discussion post report purchase.

Full Name*

Business Email* (Please avoid generic email IDs such as gmail, yahoo)

Phone* (Please Affix Country Code)

Need specific market information? To get a customized report, please share your exact research requirements.